Mosaic Therapeutics Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Mosaic Therapeutics Ltd. - overview
Established
2020
Location
Cambridge, -, UK
Primary Industry
Biotechnology
About
Based in the UK, and founded in 2020, Mosaic Therapeutics Ltd. operates as a biotechnology company that reshapes the boundaries of machine learning and experimental medicine in order to develop medicines for patients. In April, Mosaic Therapeutics Ltd. raised USD 28 million in series A funding from Cambridge Innovation Capital and Syncona Limited.
Mosaic Therapeutics Ltd. is an operator of an oncology therapeutics company aimed at cancers with significant unmet needs. Using next-generation tumor systems and advanced genomic technologies, the company uses artificial intelligence to prioritize key anti-cancer targets and genetically identify those patient groups most likely to respond to treatments developed against those targets, allowing patients to treat cancers based on their tissue of origin. The company plans to use the April funding to further develop its oncology treatments for biomarker-selected individuals, boost hiring initiatives, and expand its experimental biology, computational, and senior leadership teams.
Current Investors
Syncona , Cambridge Innovation Capital
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Oncology/Cancer Treatment
Website
www.mosaic-tx.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Mosaic Therapeutics Ltd. - timeline of key events
Mosaic Therapeutics Ltd. - financials
| Fiscal Year Ended | Sep 30, 2021 | Sep 30, 2022 |
|---|---|---|
| Revenue (USD) | - | - |
| % Revenue Growth (YoY) | - | - |
| EBITDA (USD) | - | - |
| Operating Income (USD) | - | - |
| Operating Margin | - | - |
| % EBITDA Margin | - | - |
| NET Income (USD) | - | - |
| % Net Margin | - | - |
Mosaic Therapeutics Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.